UTN- FRC -Producción Académica de Investigación y Desarrollo

Permanent URI for this communityhttp://48.217.138.120/handle/20.500.12272/1932

Browse

Author: search.filters.author.Juárez , Juliana MaríaSubject: search.filters.subject.SBA-15

Search Results

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Bimetallic platinum/iridium modified mesoporous catalysts applied in the hydrogenation of HMF.
    (Universidad Tecnológica Nacional Regional Córdoba., 2018) Ledesma , Brenda Cecilia; Juárez , Juliana María; Beltramone , Andrea Raquel; Beltramone , Andrea Raquel; Juárez , Juliana María
    The catalytic transformation of 5-hydroxymethylfurfural (HMF) to produce 2,5-dimethylfuran (DMF) was studied over bimetallic (PtIr) and monometallic (Pt) catalysts supported on CMK-3 and SBA-15 mesoporous materials. The optimum temperature and pressure for the maximum production of DMF were 120° and 15 atm. Increases in temperature and pressure decreased the selectivity to DMF. The catalysts were broadly characterized by XRD, N2-isotherms, XPS, TPR, TEM and NH3-TPD. It was found that the metal particles were well reduced and highly dispersed on the surface of the support of large surface area and narrow pore distribution. The PtIr alloy species active sites were very active and selective towards the formation of the desired DMF. PtIr-CMK-3 showed an excellent activity, selectivity and stability to be applied in this process.
  • Thumbnail Image
    Item
    Ordered mesoporous SBA-15 host for Ketorolac-Tromethamine loading and release behavior.
    (Univesidsad Tecnológica Nacional, 2017) Cussa , jorgelina; Juárez , Juliana María; Gómez Costa , Marcos Bruno; Anunziata , Oscar Alfredo; Anunziata , Oscar Alfredo; Juárez , Juliana María
    The ordered mesoporous silica SBA-15 has been applied in studies of ketorolac tromethamine adsorption and release. The SBA-15 materials with hexagonal and regular structure were obtained using a triblock copolymer Pluronic P123 as a template and TEOS as a silica source. Ketorolac tromethamine was adsorbed into SBA-15 silica nanochannels using ethanol as solvent. The physicochemical and textural properties of SBA-15 and ketorolac tromethamine/SBA-15 were characterized by X-ray diffraction, thermogravimetric analysis, transmission electron microscopy, Fourier transform infrared spectroscopy and BET surface studies. The composite SBA-15/KETO shows characteristic bands of both, drug materials and the inorganic framework. This indicates that KETO was adsorbed into SBA-15 channel surface without affecting the chemical structure or composition of KETO. Drug release was evaluated by soaking the loaded silica mesoporous material into a solution of HCl (0.1N) at initial time (0 - 2 h) and buffer pH 7 at high times at 37 ºC under continuous stirring. Oral commercial Keto tablets (Dolten®) and Keto solution (Keto power) were study for the contrast. Release studies were performed in order to evaluate the required therapeutic efficacy. SBA-15 provides significant improvement in the controlled release of ketorolac tromethamine and enhance a good analgesia effect.
  • Thumbnail Image
    Item
    Ketorolac-tromethamine contained in SBA-15 host as a drug release system,
    (Univesidsad Tecnológica Nacional, 2017) Cussa , jorgelina; Prados, Antonella; Juárez , Juliana María; Gómez Costa , Marcos Bruno; Anunziata , Oscar Alfredo; Anunziata , Oscar Alfredo; Juárez , Juliana María
    Drug delivery is an emerging field mainly focused on targeting drugs. The goal of this targeted delivery is to transport an amount of drugs to desirable sites (such as tumors and diseased tissues) while minimizing unwanted side effects of the drugs on other tissues[1]. Controlled drug delivery systems can achieve precise spatial and temporal delivery of therapeutic agents to the target site[2]. The ordered mesoporous silica SBA-15 has been applied in studies of ketorolac tromethamine adsorption and release. The SBA-15 materials with hexagonal and regular structure were obtained using a triblock copolymer Pluronic P123 as a template and TEOS as a silica source[3]. Ketorolac tromethamine was adsorbed into SBA-15 silica nanochannels using ethanol as solvent. The physicochemical and textural properties of SBA-15 and ketorolac tromethamine/SBA-15 were characterized by X-ray diffraction, thermogravimetric analysis, transmission electron microscopy, Fourier transform infrared spectroscopy and BET surface studies. Drug release was evaluated by soaking the loaded silica mesoporous material into a solution of HCl (0.1N) at initial time (0 - 2 h) and buffer pH 7 at high times at 37 ºC under continuous stirring. Oral commercial Keto tablets (Dolten®) and Keto solution (Keto power) were study for the contrast. Release studies were performed in order to evaluate the required therapeutic efficacy. In this work, we have shown a promising drug storage material for the effective encapsulation and controlled release of KETO, achieving the required therapeutic efficacy. SBA-15/KETO shows characteristic bands of both, drug materials and the inorganic framework. This indicates that KETO was adsorbed into SBA-15 channel surface without affecting the chemical structure or composition of KETO. The study also demonstrates the storage capacity and release properties of SBA-15 containing KETO. The release of KETO contained in SBA-15 can offer significant improve in controlled drug release and enhance a good analgesia effect.
  • Thumbnail Image
    Item
    Nanostructured SBA-15 host: synthesis, characterization and application in ketorolac-tromethamine release system.
    (Univesidsad Tecnológica Nacional, 2016) Cussa , jorgelina; Juárez , Juliana María; Gómez Costa, Marcos Bruno; Anunziata , Oscar Alfredo; Anunziata , Oscar Alfredo; Juárez , Juliana María
    The ordered mesoporous silica SBA-15 has been applied in studies of ketorolac tromethamine adsorption and release. The SBA-15 materials with hexagonal and regular structure were obtained using a triblock copolymer Pluronic P123 as template and TEOS as a silica source[1]. Drug delivery is an emerging field mainly focused on aiming drugs. The goal of this targeted delivery is to transport an amount of drugs to desirable sites (such as tumors and diseased tissues) while minimizing unwanted side effects of the drugs on other tissues [2]. Controlled drug delivery systems can achieve precise spatial and temporal delivery of therapeutic agents to the target site. Ketorolac tromethamine was adsorbed into SBA-15 silica nanochannels using ethanol as solvent. The physicochemical and textural properties of SBA-15 and ketorolac tromethamine/SBA-15 were characterized by X-ray diffraction, thermogravimetric analysis, transmission electron microscopy, Fourier transform infrared spectroscopy and BET surface studies. Drug release was evaluated by soaking the loaded silica mesoporous material into a solution of HCl (0.1N) at 37 ºC under continuous stirring. Release studies were performed in order to evaluate the required therapeutic efficacy. SBA-15 provides significant improvement in the controlled release of ketorolac tromethamine [3]. In this work, we have shown a promising drug storage material for the effective encapsulation and controlled release of KETO, achieving the required therapeutic efficacy. SBA-15/KETO shows characteristic bands of both, drug materials and the inorganic framework. This indicates that KETO was adsorbed into SBA-15 channel surface without affecting the chemical structure or composition of KETO. The study also demonstrates the storage capacity and release properties of SBA-15 containing KETO. The release of KETO contained in SBA-15 can offer significant improve in controlled drug release and enhance a good analgesia effect.